| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |